ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Internal Medicine

Top Internal Medicine Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
LAURA ZALCBERG M.D.

Internal Medicine

8,447

$639K

257
173 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$76
Average prescription price

Avg: $56

STEVEN DONCHEY MD

Internal Medicine

9,466

$621K

448
361 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$66
Average prescription price

Avg: $56

MANJUNATH BENAKANAHALLI MD

Internal Medicine

7,780

$502K

225
189 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

20%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $56

ANANTHI JEYABARATH MD

Internal Medicine

9,841

$483K

205
183 are 65+

26%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $56

VIJAY TAUNK M.D

Internal Medicine

8,005

$474K

242
170 are 65+

14%
patients receiving schedule two controlled substances

Avg: 5%

21%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $56

RUDOLPH EBERWEIN M.D.

Internal Medicine

5,857

$343K

164
161 are 65+

N/A
N/A

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $56

MADHURSH KUMAR M.D.

Internal Medicine

5,504

$297K

141
127 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $56

ELADIO DIEGUEZ MD

Internal Medicine

39,045

$2.01M

1058
925 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $56

MISBAH FAROOQI M.D.

Internal Medicine

33,208

$1.98M

673
465 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

37%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $56

HAMIDREZA MOGHADDAM M.D.

Internal Medicine

22,420

$1.59M

724
484 are 65+

15%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$71
Average prescription price

Avg: $56

ALEJANDRO DIZON MD

Internal Medicine

16,296

$954K

568
380 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

20%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $56

JAYANT GAJERA M.D.

Internal Medicine

20,443

$916K

419
346 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

19%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $56

VIJAY HARPALANI M.D.

Internal Medicine

14,801

$796K

472
443 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $56

SHERRI JONAS-LAZIN MD

Internal Medicine

17,439

$784K

736
685 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $56

VICTOR VALENTIN MD

Internal Medicine

13,489

$714K

438
347 are 65+

N/A

8%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $56

KISHORE PATSAMATLA MD

Internal Medicine

10,503

$643K

347
216 are 65+

24%
patients receiving schedule two controlled substances

Avg: 5%

25%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $56

GAURAV NAYYAR MD

Internal Medicine

10,536

$590K

249
190 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $56

MALCOLM FOSTER M.D.

Internal Medicine

7,269

$568K

315
150 are 65+

54%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$78
Average prescription price

Avg: $56

GLENN GIDSEG M.D.

Internal Medicine

10,064

$526K

549
413 are 65+

26%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $56

JUAN CANCIO M.D.

Internal Medicine

9,131

$508K

207
189 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

N/A

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $56

PRANGNUAN DURAND DO

Internal Medicine

7,213

$488K

191
154 are 65+

N/A

8%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$68
Average prescription price

Avg: $56

NIDAL HAMAME MD

Internal Medicine

9,292

$461K

353
282 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

22%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $56

AYMEN ATALLAH MD

Internal Medicine

6,952

$424K

366
316 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $56

STEPHEN WOYOME M.D.

Internal Medicine

6,789

$409K

174
128 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $56

DAVID FELLIN DO

Internal Medicine

6,062

$378K

310
258 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$62
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank